Found: 20
Select item for more details and to access through your institution.
Amelioration of the beta-cell dysfunction in diabetic APA hamsters by antioxidants and AGE inhibitor treatments.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Amelioration of the β-cell dysfunction in diabetic APA hamsters by antioxidants and AGE inhibitor treatments.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 3, p. 211, doi. 10.1002/dmrr.428
- By:
- Publication type:
- Article
NLRR1 regulates cell proliferation and is a potential therapeutic target in MYCN-driven malignant cancers.
- Published in:
- Experimental Animals, 2022, v. 71, p. 84
- By:
- Publication type:
- Article
Targeting KRAS G12D/V mutations by alkylating agent in PDAC mouse models.
- Published in:
- Experimental Animals, 2021, v. 70, p. 36
- By:
- Publication type:
- Article
The effects of diabetes with hyperlipidemia on P450 expression in APA hamster livers.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2002, v. 16, n. 4, p. 174, doi. 10.1002/jbt.10036
- By:
- Publication type:
- Article
Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma.
- Published in:
- Scientific Reports, 2016, p. 32682, doi. 10.1038/srep32682
- By:
- Publication type:
- Article
Gene Expression Profiling of Mouse Embryonic Stem Cell Progeny Differentiated by Lumelsky’s Protocol.
- Published in:
- Cells Tissues Organs, 2006, v. 183, n. 1, p. 24, doi. 10.1159/000094903
- By:
- Publication type:
- Article
Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257718
- By:
- Publication type:
- Article
Use of DNA‐alkylating pyrrole‐imidazole polyamides for anti‐cancer drug sensitivity screening in pancreatic ductal adenocarcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 5821, doi. 10.1002/cam4.5359
- By:
- Publication type:
- Article
Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.803443
- By:
- Publication type:
- Article
NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.669667
- By:
- Publication type:
- Article
Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole-imidazole polyamide conjugate.
- Published in:
- Nature Communications, 2015, v. 6, n. 4, p. 6706, doi. 10.1038/ncomms7706
- By:
- Publication type:
- Article
ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep03450
- By:
- Publication type:
- Article
<i>NCYM</i>, a <i>Cis</i>-Antisense Gene of <i>MYCN</i>, Encodes a <i>De Novo</i> Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 1, p. 1, doi. 10.1371/journal.pgen.1003996
- By:
- Publication type:
- Article
Estimating genome-wide off-target effects for pyrrole-imidazole polyamide binding by a pathway-based expression profiling approach.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0215247
- By:
- Publication type:
- Article
Targeting the mutant PIK3CA gene by DNA‐alkylating pyrrole‐imidazole polyamide in cervical cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 3, p. 1141, doi. 10.1111/cas.14785
- By:
- Publication type:
- Article
Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
- Published in:
- Cancer Science, 2016, v. 107, n. 9, p. 1223, doi. 10.1111/cas.13003
- By:
- Publication type:
- Article
Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.
- Published in:
- Cancer Science, 2015, v. 106, n. 10, p. 1351, doi. 10.1111/cas.12746
- By:
- Publication type:
- Article
Novel adaptor protein Shf interacts with ALK receptor and negatively regulates its downstream signals in neuroblastoma.
- Published in:
- Cancer Science, 2013, v. 104, n. 5, p. 563, doi. 10.1111/cas.12115
- By:
- Publication type:
- Article
Forced expression of NR4A3 induced the differentiation of human neuroblastoma-derived NB1 cells.
- Published in:
- 2019
- By:
- Publication type:
- journal article